NeoGenomics Laboratories is a specialized oncology reference laboratory providing the latest technologies, testing partnership opportunities, and interactive education to the oncology and pathology communities. We offer the complete spectrum of diagnostic services in molecular testing, FISH, cytogenetics, flow cytometry, and immunohistochemistry through our nation-wide network of CAP-accredited, CLIA-approved laboratories. NeoGenomics has one of the fastest test development cycles in the industry, enabling the Company to be extremely responsive to client requests, clinical guideline changes, new therapeutics, and breaking research.

NeoGenomics Pharma Services offers customizable oncology testing capabilities and expert services and leverages our reference laboratory capabilities to support drug development programs from early biomarker discovery to clinical trials, through regulatory submission and commercialization.

NeoGenomics Pharma Services offers your drug development program the most comprehensive cancer genetics test menu commercially available in the United States in a platform-agnostic environment including the following technologies: IHC, Flow Cytometry, FISH, MultiOmyxTM, PCR, Histology, Sanger & Next-Gen Sequencing, Liquid Biopsy, Cytogenetics, and Immunoassays.